Tuberculosis is a major health problem in Pakistan. The prevalence of pulmonary as well as extrapulmonary tuberculosis is quite high. Tuberculin skin test, radiological imaging, and sputum smear microscopy have limitations in the diagnosis of tuberculosis. Xpert MTB/RIF was recently approved for the diagnosis of pulmonary tuberculosis and has shown promising results. The aim of this study was to determine the diagnostic accuracy of Xpert MTB/RIF in sputum smear-negative pulmonary tuberculosis using acid-fast bacilli (AFB) culture as the gold standard.
Introduction
1 2 1 3 Tuberculosis (TB) is one among the major public health problems in Pakistan. The adjusted prevalence of smear-positive tuberculosis is 270 per 100,000 cases [1] . Moreover, in a study, the prevalence of sputum smear-negative culture positive tuberculosis was found to be 17.1% [2] . The conventional methods used for the diagnosis of TB like Tuberculin test/Montoux test, radiological examination and other imaging methods and sputum smear microscopy have their own limitations. Among them, acid-fast bacilli (AFB) staining of clinical material followed by smear microscopy is the most cost-effective, commonly applied microbiological test for diagnosis of TB but the smear positivity has to be supplemented with the culture positivity.
Mycobacterial culture is the gold standard, as it requires only 10-100 viable organisms to give a positive result while a minimum of 5000-10 000 AFB per ml are required for detection by smear [3] . However, culture is relatively slow and complex procedure. Solid culture usually takes four to eight weeks for results and liquid culture, though more rapid than solid culture, requires days for the detection of Mycobacterium tuberculosis. In addition, culture requires specialized laboratories and highly skilled staff.
In 2011, there has been introduction of World Health Organization (WHO) certified rapid, automated, cartridge-based nucleic acid amplification test (NAAT), the Xpert MTB/RIF assay (Cepheid, Sunnyvale, USA) (hereafter referred to as Xpert MTB/RIF), that can detect TB and rifampicin resistance simultaneously [4] . It generally produces results within two hours after starting the test, with minimal hands-on technical time. Xpert MTB/RIF detects both live and dead bacteria [5] . The sensitivity of a single Xpert MTB/RIF result in smear-positive, culturepositive cases is 98.2% whereas the sensitivity of a single Xpert MTB/RIF result in smearnegative, culture-positive cases is 72.5%; the sensitivity increases with repeated testing [6] . Xpert MTB/RIF has been found to be a cost-effective method for smear-negative TB diagnosis in comparison to traditional methods in resource-limited settings [7] .
Overall Xpert MTB/RIF sensitivity was 62.6%, specificity was 99.6%, PPV was 81.3%, and NPV was 98.9% in a TB prevalence study [8] . To improve patient care and decrease TB transmission, accurate and quick detection of TB especially Smear Negative and TB drug resistance is essential. To the best of our knowledge and after going through various search engines, no published data was retrieved regarding the diagnostic accuracy of Xpert MTB/RIF in sputum smear-negative pulmonary TB (PTB) in Pakistan. Therefore, the aim of this study was to determine the diagnostic accuracy of Xpert MTB/RIF in diagnosing sputum smear-negative PTB keeping AFB culture as the gold standard. 
Materials And Methods

Discussion
In this study, the sensitivity, specificity, positive predictive value, negative value, and diagnostic accuracy of Xpert MTB/RIF test were performed in a highly tuberculous population.
Our study results showed that the sensitivity of Xpert MTB/RIF for diagnosis of tuberculosis is high for diagnosis of pulmonary tuberculosis. In comparison to other studies, the sensitivity is slightly lower as reported by other authors. A study from China reported a slightly higher sensitivity as compared to our population [9] . However, another study from Ethiopia has reported a lower sensitivity of this test for diagnosis of TB [10] . The sensitivity is also higher as compared to other nucleic acid tests available for detection of Mycobacterium tuberculosis [11] . This difference in sensitivities can be due to a reason of study populations and genetic differences involved. Another difference could be due to the relative different prevalence of tuberculosis among study populations.
The results of our study showed that Xpert MTB/RIF is a highly specific test for the diagnosis of tuberculosis of pulmonary origin. This high specificity has also been reported by other studies but was slightly lower as compared to our study [10] [11] . Another study showed a slightly lower specificity among cases suspected to have sputum smear-negative pulmonary tuberculosis [12] . Another large multicentric study reported a high specificity of Xpert MTB/RIF for tuberculosis but slightly lower as compared to our study [13] . This difference can also be attributed to a difference in the population studied. Moreover, the quantity of an adequate sputum sample could also affect the specificity of this test. Similar specificity has been reported in population with a high prevalence of HIV [11] . Also the specificity of Xpert MTB/RIF is comparable to other commercial nuclear acid assays available [11] .
Our study results showed that more than 80% of smear-negative and culture-positive cases of Mycobacterium tuberculosis were detected by Xpert MTB/RIF test. Another study showed that the detection rate of smear-negative culture positive Mycobacterium cases have been lower as compared to our study [6] . The study also showed that for improvement in sensitivity of tuberculosis detection in smear-negative cases, a second test by Xpert MTB/RIF can improve sensitivity [6] .
According to the results of our study, Xpert MTB/RIF has a relatively high positive predictive value and low negative predictive value for the diagnosis of pulmonary tuberculosis. This is in contrast to an international study that has reported a high positive and negative predictive value for tuberculosis diagnosis [14] .
The results of this study are also comparable to sputum samples taken by other means using Xpert MTB/RIF for tuberculosis detection. A study utilizing fiberoptic bronchoscopy sampling for early diagnosis of sputum scarce smear-negative pulmonary tuberculosis showed a comparable sensitivity and specificity to our study [15] .
The results of our study should be considered in light to certain limitations. We did not evaluate drug-resistant mycobacteria in our study. Xpert MTB/RIF can also evaluate for rifampicin resistance in Mycobacterium and help as a viable tool for ruling out multi-drug resistant organisms. Another limitation of our study was that pediatric population was not studied. Studies have been carried out using Xpert MTB/RIF for diagnosis of tuberculosis in children and have shown promising results [16] [17] . Not evaluating extra-pulmonary tuberculosis could also account for another limitation in our study as Xpert MTB/RIF assay can be used for its evaluation [18] . However, the sampling technique for obtaining samples of different organ system is cumbersome and different invasive or semi-invasive methods are needed for their sampling.
Despite these limitations, we believe that this study is the first study from our population for the diagnosis of smear-negative pulmonary tuberculosis. The results of this study have given insights to the diagnostic accuracy of Xpert MTB/RIF in a study setting where cost limitations and high prevalence of tuberculosis exist. In addition, prospective data were collected from all the participants involved in the current study. Short study duration can be considered as a weakness of this study.
It is recommended that further studies using Xpert MTB/RIF should be done focusing on rifampicin resistance of Mycobacteria. Moreover, a study on children should be carried out in our population to further evaluate this assay.
Conclusions
The results of this study showed that Xpert MTB/RIF has high sensitivity, specificity and diagnostic accuracy in the diagnosis of pulmonary tuberculosis in sputum smear-negative patients.
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